Immunotherapeutic (investigational agent in study)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapeutic (investigational agent in study), covering 2013-07-15 to 2013-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment [Phase 2]